CASI Pharmaceuticals Ownership | Who Owns CASI Pharmaceuticals?

CASI Pharmaceuticals Ownership Summary

CASI Pharmaceuticals is owned by 0.85% institutional investors, 58.07% insiders, and 41.09% retail investors. Vr adviser is the largest institutional shareholder, holding 6.37% of CASI shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.12% of its assets in CASI Pharmaceuticals shares.

CASI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	CASI Pharmaceuticals	0.85%	58.07%	41.09%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vr adviser	987.26K	6.37%	$1.64M
Foresite capital management vi	979.96K	6.32%	$1.63M
Woodline partners lp	165.64K	1.07%	$274.96K
Wellington shields capital management	69.53K	0.45%	$115.43K
Renaissance	43.90K	0.28%	$72.87K
Two sigma investments, lp	33.27K	0.21%	$55.22K
Wellington shields	30.09K	0.19%	$49.95K
Geode capital management	18.81K	0.12%	$31.22K
Ground swell capital	10.13K	0.07%	$16.82K
Royal bank of canada	9.95K	0.06%	$16.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Foresite capital management vi	979.96K	0.63%	$1.63M
Vr adviser	987.26K	0.09%	$1.64M
Ground swell capital	10.13K	0.04%	$16.82K
Wellington shields capital management	69.53K	0.02%	$115.43K
Wellington shields	30.09K	0.01%	$49.95K
Woodline partners lp	165.64K	0.00%	$274.96K
Two sigma investments, lp	33.27K	0.00%	$55.22K
Renaissance	43.90K	0.00%	$72.87K
Advisornet financial	-	-	-
Northwestern mutual wealth management	13.00	-	$22.00

Top Buyers

Holder	Shares	% Assets	Change
Foresite capital management vi	979.96K	0.63%	192.84K
Two sigma investments, lp	33.27K	0.00%	33.27K
Ground swell capital	10.13K	0.04%	10.13K
Renaissance	43.90K	0.00%	4.70K
Group one trading	2.30K	-	2.30K

Top Sellers

Holder	Shares	% Assets	Change
Adar1 capital management	-	-	-44.12K
Wellington shields capital management	69.53K	0.02%	-21.31K
Two sigma securities	-	-	-11.60K
Ubs group	14.00	-	-940.00
West paces advisors	-	-	-100.00

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma investments, lp	33.27K	0.00%	33.27K	$55.22K
Ground swell capital	10.13K	0.04%	10.13K	$16.82K
Group one trading	2.30K	-	2.30K	$3.82M

Sold Out

Holder	Change
Citigroup	-19.00
Advisornet financial	-26.00
West paces advisors	-100.00
Two sigma securities	-11.60K
Adar1 capital management	-44.12K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	9	-57.14%	131,206	-94.06%	-	0.42%	2	-66.67%	1	-83.33%
Jun 30, 2025	23	4.55%	2,245,418	-18.18%	14	4.62%	7	-	7	250.00%
Mar 31, 2025	22	-	2,744,278	3.24%	17	5.90%	7	16.67%	2	-66.67%
Dec 31, 2024	22	-	2,658,168	100.99%	17	23.17%	6	-14.29%	6	200.00%
Sep 30, 2024	22	-8.33%	1,322,529	275.22%	8	127.21%	7	-30.00%	2	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	18.81K	0.12%	-
NT Quality SCC US Fund - L	1.93K	0.01%	-180.00
NT Quality Small Cap Core	1.93K	0.01%	-180.00
JNL/DFA US Small Cap A	1.67K	0.01%	-
Dimensional US Small Cap CIT Class S	1.03K	0.01%	-
Dimensional US Sm Company EUR Acc	307.00	0.00%	1.00
AZL® DFA US Small Cap	142.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 06, 2022	Huang James		Buy	$142.63K
Aug 31, 2022	Huang James		Buy	$1.50K
Aug 24, 2022	Huang James		Buy	$148.18K
Aug 19, 2022	Huang James		Buy	$139.99K
Jun 15, 2022	He Wei-Wu	Chairman and CEO	Buy	$159.00K

Insider Transactions Trends

Date	Buy	Sell
2022 Q3	4	-
2022 Q2	1	-
2021 Q4	2	-
2021 Q3	2	-
2021 Q2	-	-

CASI Ownership FAQ

Who Owns CASI Pharmaceuticals?

CASI Pharmaceuticals shareholders are primarily institutional investors at 0.85%, followed by 58.07% insiders and 41.08% retail investors. The average institutional ownership in CASI Pharmaceuticals's industry, Biotech Stocks , is 45.24%, which CASI Pharmaceuticals falls below.

Who owns the most shares of CASI Pharmaceuticals?

CASI Pharmaceuticals’s largest shareholders are Vr adviser (987.26K shares, 6.37%), Foresite capital management vi (979.96K shares, 6.32%), and Woodline partners lp (165.64K shares, 1.07%). Together, they hold 13.76% of CASI Pharmaceuticals’s total shares outstanding.

Does Blackrock own CASI Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of CASI Pharmaceuticals.

Who is CASI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Foresite capital management vi is CASI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.63% of its assets in 979.96K CASI Pharmaceuticals shares, valued at 1.63M$.

Who is the top mutual fund holder of CASI Pharmaceuticals shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of CASI Pharmaceuticals shares, with 0.12% of its total shares outstanding invested in 18.81K CASI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools